Liquid Biopsy Market to Grow at 13.1% CAGR, Revolutionizing Cancer Diagnostics
The global liquid biopsy market is projected to grow significantly, with an estimated value of USD 35.3 billion by 2033, up from USD 10.3 billion in 2023, reflecting a compound annual growth rate (CAGR) of 13.1% during the forecast period from 2023 to 2033. This growth is driven by several key factors, including the increasing prevalence of cancer, advancements in technology, and the rising adoption of non-invasive diagnostic methods. One of the primary growth drivers is the increasing incidence of cancer worldwide, which has fueled the demand for less invasive and more accurate diagnostic tools like liquid biopsies. These tests…
- Date: May 15, 2024
- Author: Robert Shaw
- Category: PharmiWeb